Genenta Science S.p.A. (GNTA)

3,7000 +0,2800 (+8,19%) Börsenschluss: 04:00PM EDT

Genenta Science S.p.A.

Via Olgettina No. 58
Milan, MI 20132
Italy

https://www.genenta.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 14

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Pierluigi Paracchi	Vice Chairman of the Board, CEO & GM	N/A	N/A	1973
Dr. Luigi Naldini M.D., Ph.D.	Co-Founder & Chairman of the Executive Scientific Board	N/A	N/A	1959
Dr. Bernard Rudolph Gentner M.D., Ph.D.	Co-Founder & Member of the Executive Scientific Board	N/A	N/A	1975
Mr. Richard B. Slansky	Chief Financial Officer	N/A	N/A	1958
Dr. Carlo Russo M.D.	Chief Medical Officer & Head of Development	N/A	N/A	1953
Dr. Stefania Mazzoleni Ph.D.	Director of Program Development	N/A	N/A	1982
Ms. Barbara Regonini	Director of Finance	N/A	N/A	1973

Die Beträge haben den Stand und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Corporate Governance

Genenta Science S.p.A.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.